491 related articles for article (PubMed ID: 22941023)
1. Yttrium 90 microspheres for the treatment of hepatocellular carcinoma.
Memon K; Lewandowski RJ; Riaz A; Salem R
Recent Results Cancer Res; 2013; 190():207-24. PubMed ID: 22941023
[TBL] [Abstract][Full Text] [Related]
2. Radioembolization for primary and metastatic liver cancer.
Memon K; Lewandowski RJ; Kulik L; Riaz A; Mulcahy MF; Salem R
Semin Radiat Oncol; 2011 Oct; 21(4):294-302. PubMed ID: 21939859
[TBL] [Abstract][Full Text] [Related]
3. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
Wang EA; Stein JP; Bellavia RJ; Broadwell SR
Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319
[TBL] [Abstract][Full Text] [Related]
4. Yttrium-90 microspheres (TheraSphere and SIR-Spheres) for the treatment of unresectable hepatocellular carcinoma.
Allison C
Issues Emerg Health Technol; 2007 Sep; (102):1-6. PubMed ID: 17824141
[TBL] [Abstract][Full Text] [Related]
5. Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review.
Lee EW; Alanis L; Cho SK; Saab S
Korean J Radiol; 2016; 17(4):472-88. PubMed ID: 27390539
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
[TBL] [Abstract][Full Text] [Related]
7. Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis.
Iñarrairaegui M; Thurston KG; Bilbao JI; D'Avola D; Rodriguez M; Arbizu J; Martinez-Cuesta A; Sangro B
J Vasc Interv Radiol; 2010 Aug; 21(8):1205-12. PubMed ID: 20598574
[TBL] [Abstract][Full Text] [Related]
8. Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity.
Padia SA; Kwan SW; Roudsari B; Monsky WL; Coveler A; Harris WP
J Vasc Interv Radiol; 2014 Jul; 25(7):1067-73. PubMed ID: 24837982
[TBL] [Abstract][Full Text] [Related]
9. (90)Y-glass microspheres for hepatic neoplasia.
Mahnken AH
Future Oncol; 2015; 11(9):1343-54. PubMed ID: 25952780
[TBL] [Abstract][Full Text] [Related]
10. Survival benefit of radioembolization for inoperable hepatocellular carcinoma using yttrium-90 microspheres.
Kwok PC; Leung KC; Cheung MT; Lam TW; Szeto LT; Chou SQ; Chia NH; Tong CM; Yuen PK; Cheung CH; Law CK
J Gastroenterol Hepatol; 2014 Nov; 29(11):1897-904. PubMed ID: 24734957
[TBL] [Abstract][Full Text] [Related]
11. Yttrium-90 Radioembolization for Hepatocellular Carcinoma.
Hickey RM; Lewandowski RJ; Salem R
Semin Nucl Med; 2016 Mar; 46(2):105-8. PubMed ID: 26897714
[TBL] [Abstract][Full Text] [Related]
12. Histological changes in nontumoral liver secondary to radioembolization of hepatocellular carcinoma with yttrium 90-impregnated microspheres: report of two cases.
Dhingra S; Schwartz M; Kim E; Mabel Ko H; Ward SC; Fiel MI; Thung SN
Semin Liver Dis; 2014 Nov; 34(4):465-8. PubMed ID: 25369308
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Adverse Event Profile of TheraSphere
Kallini JR; Gabr A; Thorlund K; Balijepalli C; Ayres D; Kanters S; Ebrahim S; Mills E; Lewandowski RJ; Salem R
Cardiovasc Intervent Radiol; 2017 Jul; 40(7):1033-1043. PubMed ID: 28246879
[TBL] [Abstract][Full Text] [Related]
14. Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience.
Tohme S; Sukato D; Chen HW; Amesur N; Zajko AB; Humar A; Geller DA; Marsh JW; Tsung A
J Vasc Interv Radiol; 2013 Nov; 24(11):1632-8. PubMed ID: 24160821
[TBL] [Abstract][Full Text] [Related]
15. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review.
Salem R; Hunter RD
Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S83-8. PubMed ID: 16979447
[TBL] [Abstract][Full Text] [Related]
16. Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates.
Keng GH; Sundram FX; Yu SW; Somanesan S; Premaraj J; Oon CJ; Kwok R; Htoo MM
Ann Acad Med Singap; 2002 May; 31(3):382-6. PubMed ID: 12061301
[TBL] [Abstract][Full Text] [Related]
17. Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe.
Burgmans MC; Kao YH; Irani FG; Dames EL; Teo TK; Goh AS; Chow PK; Tay KH; Lo RH
J Vasc Interv Radiol; 2012 Oct; 23(10):1294-301. PubMed ID: 22922039
[TBL] [Abstract][Full Text] [Related]
18. Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival.
Hilgard P; Hamami M; Fouly AE; Scherag A; Müller S; Ertle J; Heusner T; Cicinnati VR; Paul A; Bockisch A; Gerken G; Antoch G
Hepatology; 2010 Nov; 52(5):1741-9. PubMed ID: 21038413
[TBL] [Abstract][Full Text] [Related]
19. Locoregional therapy for hepatocellular carcinoma: radioembolization with yttrium-90 microspheres.
Herzer K; Müller S; Antoch G; Hilgard P
Minerva Gastroenterol Dietol; 2011 Sep; 57(3):287-98. PubMed ID: 21769078
[TBL] [Abstract][Full Text] [Related]
20. Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan.
Chiesa C; Maccauro M; Romito R; Spreafico C; Pellizzari S; Negri A; Sposito C; Morosi C; Civelli E; Lanocita R; Camerini T; Bampo C; Bhoori S; Seregni E; Marchianò A; Mazzaferro V; Bombardieri E
Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):168-97. PubMed ID: 21386789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
